Drug profile · INN
quetiapine
SEROQUEL XR
quetiapine (SEROQUEL XR) is a serotonin 2c (5-ht2c) receptor antagonist. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 9
News articles 0
Drug details — quetiapine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 9
- Data quality
- 0.81
Quick answer
quetiapine (SEROQUEL XR) is a serotonin 2c (5-ht2c) receptor antagonist. Associated with Alphapharm Pty Ltd.
Key facts
INN quetiapine
Brand SEROQUEL XR
Mechanism Serotonin 2c (5-HT2c) receptor antagonist
Originator Alphapharm Pty Ltd
Mechanism of action
Serotonin 2c (5-HT2c) receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is quetiapine?
quetiapine (SEROQUEL XR) is a serotonin 2c (5-ht2c) receptor antagonist. Associated with Alphapharm Pty Ltd.
What is the brand name for quetiapine?
SEROQUEL XR is a marketed brand name for quetiapine. Check FDA Drugs@FDA for the current US label holder and prescribing information.